JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graham, K. L.
Right arrow Articles by Coulson, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graham, K. L.
Right arrow Articles by Coulson, B. S.
Journal of Virology, November 2004, p. 11786-11797, Vol. 78, No. 21
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.21.11786-11797.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Effects on Rotavirus Cell Binding and Infection of Monomeric and Polymeric Peptides Containing {alpha}2ß1 and {alpha}xß2 Integrin Ligand Sequences

Kate L. Graham,1 Weiguang Zeng,1,2 Yoshikazu Takada,3 David C. Jackson,1,2 and Barbara S. Coulson1*

Department of Microbiology and Immunology,1 Cooperative Research Centre for Vaccine Technology, Department of Microbiology and Immunology, University of Melbourne, Victoria, Australia,2 UC Davis Medical Center, University of California-Davis, Sacramento, California3

Received 27 April 2004/ Accepted 28 June 2004

Integrin-using rotaviruses bind MA104 cell surface {alpha}2ß1 integrin via the Asp-Gly-Glu (DGE) sequence in virus spike protein VP4 and interact with {alpha}xß2 integrin during cell entry through outer capsid protein VP7. Infection is inhibited by the {alpha}2ß1 ligand Asp-Gly-Glu-Ala (DGEA) and the {alpha}xß2 ligand Gly-Pro-Arg-Pro (GPRP), and virus-{alpha}2ß1 binding is increased by {alpha}2ß1 activation. In this study, we analyzed the effects of monomers and polymers containing DGEA-, GPRP-, and DGEA-related peptides on rotavirus binding and infection in intestinal (Caco-2) and kidney (MA104) cells and virus binding to recombinant {alpha}2ß1. Blockade of rotavirus-cell binding and infection by peptides and anti-{alpha}2 antibody showed that Caco-2 cell entry is dependent on virus binding to {alpha}2ß1 and interaction with {alpha}xß2. At up to 0.5 mM, monomeric DGEA and DGAA inhibited binding to {alpha}2ß1 and infection. At higher concentrations, DGEA and DGAA showed a reduced ability to inhibit virus-cell binding and infection that depended on virus binding to {alpha}2ß1 but occurred without alteration in cell surface expression of {alpha}2, ß2, or {alpha}vß3 integrin. This loss of DGEA activity was abolished by genistein treatment and so was dependent on tyrosine kinase signaling. It is proposed that this signaling activated existing cell surface {alpha}2ß1 to increase virus-cell attachment and entry. Polymeric peptides containing DGEA and GPRP or GPRP only were inhibitory to SA11 infection at approximately 10-fold lower concentrations than peptide monomers. As polymerization can improve peptide inhibition of virus-receptor interactions, this approach could be useful in the development of inhibitors of receptor recognition by other viruses.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, Gate 11, Royal Parade, The University of Melbourne, Melbourne, Victoria 3010, Australia. Phone: 61 3 8344 8823. Fax: 61 3 9347 1540. E-mail: barbarac{at}unimelb.edu.au.


Journal of Virology, November 2004, p. 11786-11797, Vol. 78, No. 21
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.21.11786-11797.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.